State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Teva Pharmaceuticals USA Inc Released in Allergan Opioid Deal
Trusted by teams at
Description
Under the Allergan opioid settlement approved by New Hampshire courts, Teva Pharmaceuticals USA, Inc. will be released from opioid-related claims, as part of annual national payments through 2029.
Contract Details
Contract Amount
Part of Allergan Public Global Opioid Settlement Agreement, aggregate maximum $2,372,972,184.12 nationally, no NH-specific amount stated.
Vendor
TEVA PHARMACEUTICALS USA INC
Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee), NH
Contract Type
OTHER
Document Date
September 12, 2023
Contract Term
Annual payment schedule through July 15, 2029
Renewal Date
2029-07-15
Renewal Info
Non-renewable; amendment or modification only by written, court-approved consent of all parties.
More from TEVA PHARMACEUTICALS USA INC
Related Contracts
Issuing Agency
New Hampshire AG | (Domestic Violence Fatality Review Committee)
State
Concord, NH
More from New Hampshire AG | (Domestic Violence Fatality Review Committee)
New Hampshire Victim Services Funding RFP SFY27VS01 March 2026
State of New Hampshire v. Publicis Health, LLC Assurance of Discontinuance Feb 2024
State of New Hampshire v. Allergan Limited et al. Consent Judgment Sept 2023
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Merrimack Superior Court Consent Judgment and Dismissal Teva Global Opioid Settlement 2023-09-12
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.